Bringing AI to Clinicians: Simplifying Pleural Effusion Cytology Diagnosis with User-Friendly Models.

Journal: Diagnostics (Basel, Switzerland)
Published Date:

Abstract

Malignant pleural effusions (MPEs) are common in advanced lung cancer patients. Cytological examination of pleural fluid is essential for identifying cell types but presents diagnostic challenges, particularly when reactive mesothelial cells mimic neoplastic cells. AI-powered diagnostic systems have emerged as valuable tools in digital cytopathology. This study explores the applicability of machine-learning (ML) models and highlights the importance of accessible tools for clinicians, enabling them to develop AI solutions and make advanced diagnostic tools available even in resource-limited settings. The focus is on differentiating normal/reactive cells from neoplastic cells in pleural effusions linked to lung adenocarcinoma. A dataset from the Cytopathology Unit at the Sant'Andrea University Hospital comprising 969 raw images, annotated with 3130 single mesothelial cells and 3260 adenocarcinoma cells, was categorized into two classes based on morphological features. Object-detection models were developed using YOLOv8 and the latest YOLOv11 instance segmentation models. The models achieved an Intersection over Union (IoU) score of 0.72, demonstrating robust performance in class prediction for both categories, with YOLOv11 showing performance improvements over YOLOv8 in different metrics. The application of machine learning in cytopathology offers clinicians valuable support in differential diagnosis while also expanding their ability to engage with AI tools and methodologies. The diagnosis of MPEs is marked by substantial morphological and technical variability, underscoring the need for high-quality datasets and advanced deep-learning models. These technologies have the potential to enhance data interpretation and support more effective clinical treatment strategies in the era of precision medicine.

Authors

  • Enrico Giarnieri
    Cytopathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Elisabetta Carico
    Cytopathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Stefania Scarpino
    Morphologic and Molecular Pathology Unit, Department of Clinical and Molecular Medicine, Sant' Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Alberto Ricci
    Respiratory Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Pierdonato Bruno
    Respiratory Disease Unit, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
  • Simone Scardapane
    Department of Information Engineering, Electronics and Telecommunications (DIET), "Sapienza" University of Rome, Via Eudossiana 18, 00184 Rome, Italy.
  • Daniele Giansanti
    Centro Nazionale TISP, Istituto Superiore di Sanità; Viale Regina Elena 299, 00161 Roma, Italy.

Keywords

No keywords available for this article.